Health — 06 May 2013

Pregnant_woman2By Pat Anson, Editor

The Food and Drug Administration is warning pregnant women not to use migraine drugs containing valproate sodium because they could lower the IQs of their unborn children.

The warning applies to several migraine medications, including Depacon, Depakote, Depakene, Stavzor and their generics. Drugs containing valproate are also used to treat epilepsy seizures and manic depressive episodes caused by bipolar disorder. Some doctors prescribe the drugs off label to treat psychiatric conditions.

“Valproate medications should never be used in pregnant women for the prevention of migraine headaches because we have even more data now that show the risks to the children outweigh any treatment benefits for this use,” said Russell Katz, MD, director of the FDA’s Division of Neurology Products.

Read more at National Pain Report.

Share

About Author

Pat Anson, Editor

Pat is Editor in Chief of American News Report. He is a veteran journalist and a former correspondent and producer for HealthWeek (PBS), Nightly Business Report (PBS) and other nationally syndicated shows. Pat has won numerous journalism awards, including a Golden Mike award for investigative reporting.

(0) Readers Comments

Comments are closed.